Impaired insulin secretion and uptake in patients with diffuse idiopathic skeletal hyperostosis

Endocrine Regulations

Volumn 43, Issue 4, 2009, Pages 149-155

  Eckertova, M ^a   Krskova, K ^a   Penesova, A ^a   Radikova, Z ^a   Zlnay, D ^b   Rovensky, J ^b   Zorad, S ^a  

^a INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^b NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

Author keywords

Diffuse idiopathic skeletal hyperostosis; Glucose metabolism; Insulin secretion

Indexed keywords

C PEPTIDE; CHOLESTEROL; FATTY ACID; GLUCOSE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRIACYLGLYCEROL; URIC ACID; HUMAN GROWTH HORMONE; LIPID;

ADULT; ANKYLOSING HYPEROSTOSIS; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; METABOLIC PARAMETERS; ORAL GLUCOSE TOLERANCE TEST; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; BLOOD; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION;

BLOOD GLUCOSE; C-PEPTIDE; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN GROWTH HORMONE; HUMANS; HYPEROSTOSIS, DIFFUSE IDIOPATHIC SKELETAL; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-SECRETING CELLS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 77949498140     PISSN: 12100668     EISSN: 13360329     Source Type: Journal    
DOI: 10.4149/endo_2009_04_149     Document Type: Article

References (30)

1. Altomonte L, Zoli A, Mirone L, Marchese G, Scolieri P, Barini A, Marago M: Growth hormone secretion in diffuse idiopathic skeletal hyperostosis. Ann Ital Med Int 7, 30-33, 1992
2. Brixen K, Nielsen HK, Mosekilde L, Flyvbjerg A: A short course of rhGH stimulates osteoblasts and activates bone remodeling in normal human volunteers. J Bone Miner Res 5, 609-618, 1990
3. Cederholm J, Wibell L: Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 10, 167-175, 1990 doi:10.1016/0168-8227(90)90040-Z
4. Denko CW, Boja B, Moskowitz RW: Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis- insulin, insulin-like growth factor-I, growth hormone. J Rheumatol 21, 1725-1730, 1994
5. Denko CW, Boja B, Malemud CJ: Growth hormone and insulin-like growth factor-I in symptomatic and asymptomatic patients with diffuse idiopathic skeletal hyperostosis (DISH). Front Biosci 7, 37-43, 2002 doi:10.2741/denko
6. Doshi LS, Brahma MK, Sayeed SG, Dixit AV, Chandrak PG, Pamidiboina V, Mottwala HF, Sharma SD, Nemmani KV: Acute administration of GPR40 receptor agonist potentiates glucose-stimulated insulin secretion in vivo in the rat. Metabolism 58, 333-343, 2009 doi:10.1016/j.metabol.2008.10.005
7. Forestier J, Rotes-Querol J: Senile ankylosing hyperostosis of the spine. Ann Rheum Dis. 9, 321-330, 1950 doi:10.1136/ard.9.4.321
8. Forestier J, Lagier R: Ankylosing hyperostosis of the spine. Clin Orthop 74, 65-83, 1971 doi:10.1097/00003086-197101000-00009
9. Gutt M, Davis CL, Spitzer SB, Llabre MM, Kumar M, Czarnecki EM, Schneiderman N, Skyler JS, Marks JB: Validation of the insulin sensitivity index (ISI0, 120): comparison with other measures. Diabetes Res Clin Pract 47, 177-184, 2000 doi:10.1016/S0168-8227(99)00116-3
10. Kanauchi M, Nakajima M, Saito Y, Kanauchi K: Pancreatic beta-cell function and insulin sensitivity in Japanese subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus. Metabolism 52, 476-481, 2003 doi:10.1053/meta.2003.50078
11. Kiss C, Szilagyi M, Paksy A, Poor G: Risk factors for diffuse idiopathic skeletal hyperostosis: a case-control study. Rheumatology (Oxford) 41, 27-30, 2002 doi:10.1093/rheumatology/41.1.27
12. Littlejohn GO, Smythe HA: Marked hyperinsulinemia after glucose challenge in patients with diffuse idiopathic skeletal hyperostosis. J Rheumatol 8, 965-968, 1981
13. Littlejohn GO, Hall S: Diffuse idiopathic skeletal hyperostosis and new bone formation in male gouty subjects. A radiologic study. Rheumatol Int 2, 83-86, 1982 doi:10.1007/BF00541250
14. Littlejohn GO: Insulin and new bone formation in diffuse idiopathic skeletal hyperostosis. Clin Rheumatol 4, 294-300, 1985 doi:10.1007/BF02031611
15. Mader R: Diffuse idiopathic skeletal hyperostosis: isolated involvement of cervical spine in a young patient. J Rheumatol 31, 620-621, 2004
16. Mader R, Lavi I: Diabetes mellitus and hypertension as risk factors for early diffuse idiopathic skeletal hyperostosis (DISH). Osteoarthritis Cartilage 17, 825-828, 2009 doi:10.1016/j.joca.2008.12.004
17. Mata S, Fortin PR, Fritcharles MA, Starr MR, Joseph L, Watis CS, Gore B, Rosenberg E, Chhem RK, Esdaile JM: A controlled study of diffuse idiopathic skeletal hyperostosis. Medicine 76, 104-117, 1997 doi:10.1097/00005792-199703000-00003
18. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462-1470, 1999 doi:10.2337/diacare.22.9.1462
19. El Miedany YM, Wassif G, El Baddiny M: Diffuse idiopathic skeletal hyperostosis (DISH): Is it of vascular etiology? Clin Exp Rheumatol 18, 193-200, 2000
20. Moskowitz RW, Boja B, Denko JW: The role of growth factor in degenerative joint disorders. J Rheumatol 18, 147-148, 1991
21. Pavelkova A, Pavelka K: Diffuse idiopathic skeletal hyperostosis and its relation to metabolic parameters (in Czech). Vnitr. Lek. 52, 477-480, 2006
22. Radikova Z, Koska J, Huckova M, Ksinantova L, Imrich R, Vigas M, Trnovec T, Langer P, Sebokova E, Klimes I: Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects. Exp Clin Endocrinol Diabetes 114, 249-256, 2006 doi:10.1055/s-2006-924233
23. Resnick D, Shaul SR, Robin JM: Diffuse idiopathic skeletal hyperostosis (DISH): Forestier's disease with extraspinal manifestation. Radiology 115, 513-524, 1975
24. Seltzer HS, Allen W, Herron AL, Brennan MT: Insulin secretion in response to glycemic stimulus: Relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 46, 323-334, 1967 doi:10.1172/JCI105534
25. Smythe H, Littlejohn G: Diffuse idiopathic skeletal hyperostosis. In: Klippel JH, Dieppe P, eds. Rheumatology. London: Mosby, 7, 9.1-9.6, 1994
26. Troilet N, Gerster JC: Forestier disease and metabolism disorders. A prospective controlled study of 25 casts. Rev Rheum Ed Fr 60, 274-279, 1993
27. Ukropec J, Penesova A, Skopkova M, Pura M, Vlcek M, Radikova Z, Imrich R, Ukropcova B, Tajtakova M, Koska J, Zorad S, Belan V, Vanuga P, Payer J, Eckel J, Klimes I, Gasperikova D: Adipokine protein expression pattern in growth hormone deficiency predisposes to the increased fat cell size and the whole body metabolic derangements. J Clin Endocrinol Metab 93, 2255-2262, 2008 doi:10.1210/jc.2007-2188
28. Vezyroglu G, Mitropoulos A, Kyriazis N, Antoniadis C: A metabolic syndrome in diffuse idiopathic skeletal hyperostosis: a controlled study. J Rheumatol 23, 672-676, 1996
29. Weinfeld RM, Olson PN, Maki DD, Griffiths HJ: The prevalence of diffuse idiopathic skeletal hyperostosis (DISH) in two large American Midwest metropolitan hospital populations. Skeletal Radiol 26, 222-225, 1997 doi:10.1007/s002560050225
30. Zlnay D, Vigas M, Sitaj S, Svec V, Ondrasik M: Sacharide metaboism and ankylosing hyperostosis Reumatologia 2 219-222, 18